AI therapist takes on depression and anxiety in new trial

NCT ID NCT07576686

Recruiting now Symptom relief Sponsor: Aleksandra Stojanovic Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether an AI-guided cognitive behavioral therapy program can reduce symptoms of mild depression and anxiety in adults. Over 10 weeks, 120 participants will either receive AI-guided therapy through a digital platform or standard care. The goal is to see if AI can make effective therapy more accessible.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AI-guided cognitive behavioral therapy
What this could lead to: If successful, this could provide a scalable, accessible digital therapy option for people with mild depression or anxiety, reducing wait times for care.
What could go wrong: This is an early-stage trial with only 120 participants, so results may not apply broadly. The AI therapy may be less effective than in-person therapy, and technical issues could limit engagement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder Depression dysthymic disorder major depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANXIETY DISORDERS DEPRESSION - MAJOR DEPRESSIVE DISORDER

Contacts and locations

Locations

University Clinical Center Niš
RECRUITING

Niš, 18000, Serbia

More trials for these conditions

Other studies related to the condition(s) this trial covers.